Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0406
+0.0056 (16.00%)
At close: Aug 14, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $2.04 million as of August 14, 2026. Its market cap has increased by 75.57% in one year.
Market Cap
2.04M
Enterprise Value
2.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
ChartMarket Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 2.04M, a decrease of -93.46%. That is a compound annual growth rate of -13.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.04M | 268.25% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 2.84M |
| CASI Pharmaceuticals | 2.71M |
| Enzolytics | 2.66M |
| International Stem Cell | 2.61M |
| Vaccinex | 2.56M |
| AccuStem Sciences | 2.43M |
| VitaSpring Biomedical | 2.30M |
| AXIM Biotechnologies | 1.92M |